Peripheral Leukocytosis Predicts Cognitive Decline but Not Behavioral Disturbances: A Nationwide Study of Alzheimer's and Parkinson's Disease Patients

Overview

Journal Dement Geriatr Cogn Disord

Publisher Karger

Specialties Geriatrics
Neurology
Psychiatry

Date 2021 May 31

PMID 34058741

Citations 2

Authors

Santiago R Unda

Aldana M Antoniazzi

David J Altschul

Roberta Marongiu

Affiliations

Soon will be listed here.

Abstract

Introduction: Peripheral and central nervous system inflammation have been linked to the classic symptoms of Parkinson's disease (PD) and Alzheimer's disease (AD). However, it remains unclear whether the analysis of routine systemic inflammatory markers could represent a useful prediction tool to identify clinical subtypes in patients with Parkinson's and Alzheimer's at higher risk of dementia-associated symptoms, such as behavioral and psychological symptoms of dementia (BPSD).

Methods: We performed a multivariate logistic regression using the 2016 and 2017 National Inpatient Sample with International Classification of Diseases 10th edition codes to assess if pro-inflammatory white blood cells (WBCs) anomalies correlate with dementia and BPSD in patients with these disorders.

Results: We found that leukocytosis was the most common WBC inflammatory marker identified in 3.9% of Alzheimer's and 3.3% Parkinson's patients. Leukocytosis was also found to be an independent risk factor for Parkinson's dementia. Multivariate analysis of both cohorts showed that leukocytosis is significantly decreased in patients with BPSD compared to patients without BPSD.

Conclusions: These results suggest a link between leukocytosis and the pathophysiology of cognitive dysfunction in both PD and AD. A better understanding of the role of systemic neuroinflammation on these devastating neurodegenerative disorders may facilitate the development of cost-effective blood biomarkers for patient's early diagnosis and more accurate prognosis.

Citing Articles

Cysteine Donor-Based Brain-Targeting Prodrug: Opportunities and Challenges.

Ni G, Hu Z, Wang Z, Zhang M, Liu X, Yang G Oxid Med Cell Longev. 2022; 2022:4834117.

PMID: 35251474 PMC: 8894025. DOI: 10.1155/2022/4834117.

Novel Insights into the Role of Probiotics in Respiratory Infections, Allergies, Cancer, and Neurological Abnormalities.

Balta I, Butucel E, Mohylyuk V, Criste A, Dezmirean D, Stef L Diseases. 2021; 9(3).

PMID: 34562967 PMC: 8482260. DOI: 10.3390/diseases9030060.

References

Joshi N, Singh S . Updates on immunity and inflammation in Parkinson disease pathology. J Neurosci Res. 2017; 96(3):379-390. DOI: 10.1002/jnr.24185. View

Bu X, Yao X, Jiao S, Zeng F, Liu Y, Xiang Y . A study on the association between infectious burden and Alzheimer's disease. Eur J Neurol. 2014; 22(12):1519-25. DOI: 10.1111/ene.12477. View

Sankowski R, Mader S, Valdes-Ferrer S . Systemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration. Front Cell Neurosci. 2015; 9:28. PMC: 4313590. DOI: 10.3389/fncel.2015.00028. View

Lin C, Chiu S, Chen T, Jang J, Chiu M . Classifications of Neurodegenerative Disorders Using a Multiplex Blood Biomarkers-Based Machine Learning Model. Int J Mol Sci. 2020; 21(18). PMC: 7555120. DOI: 10.3390/ijms21186914. View

Bu X, Wang X, Xiang Y, Shen L, Wang Q, Liu Y . The association between infectious burden and Parkinson's disease: A case-control study. Parkinsonism Relat Disord. 2015; 21(8):877-81. DOI: 10.1016/j.parkreldis.2015.05.015. View

Goldman J, Vernaleo B, Camicioli R, Dahodwala N, Dobkin R, Ellis T . Cognitive impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health. NPJ Parkinsons Dis. 2018; 4:19. PMC: 6018742. DOI: 10.1038/s41531-018-0055-3. View

Walker K . Inflammation and neurodegeneration: chronicity matters. Aging (Albany NY). 2018; 11(1):3-4. PMC: 6339781. DOI: 10.18632/aging.101704. View

Tracey K . The inflammatory reflex. Nature. 2002; 420(6917):853-9. DOI: 10.1038/nature01321. View

Wallings R, Herrick M, Tansey M . LRRK2 at the Interface Between Peripheral and Central Immune Function in Parkinson's. Front Neurosci. 2020; 14:443. PMC: 7253584. DOI: 10.3389/fnins.2020.00443. View

10.

Aarsland D, Andersen K, Larsen J, Lolk A, Nielsen H, Kragh-Sorensen P . Risk of dementia in Parkinson's disease: a community-based, prospective study. Neurology. 2001; 56(6):730-6. DOI: 10.1212/wnl.56.6.730. View

11.

Chiu P, Tsai C, Chen P, Chen W, Lai T . Neuropsychiatric Symptoms in Parkinson's Disease Dementia Are More Similar to Alzheimer's Disease than Dementia with Lewy Bodies: A Case-Control Study. PLoS One. 2016; 11(4):e0153989. PMC: 4839640. DOI: 10.1371/journal.pone.0153989. View

12.

McKhann G, Knopman D, Chertkow H, Hyman B, Jack Jr C, Kawas C . The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7(3):263-9. PMC: 3312024. DOI: 10.1016/j.jalz.2011.03.005. View

13.

Serpente M, Bonsi R, Scarpini E, Galimberti D . Innate immune system and inflammation in Alzheimer's disease: from pathogenesis to treatment. Neuroimmunomodulation. 2014; 21(2-3):79-87. DOI: 10.1159/000356529. View

14.

Finkel S, Costa E Silva J, Cohen G, Miller S, Sartorius N . Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr. 1996; 8 Suppl 3:497-500. DOI: 10.1017/s1041610297003943. View

15.

. 2016 Alzheimer's disease facts and figures. Alzheimers Dement. 2016; 12(4):459-509. DOI: 10.1016/j.jalz.2016.03.001. View

16.

Lindqvist D, Kaufman E, Brundin L, Hall S, Surova Y, Hansson O . Non-motor symptoms in patients with Parkinson's disease - correlations with inflammatory cytokines in serum. PLoS One. 2012; 7(10):e47387. PMC: 3474801. DOI: 10.1371/journal.pone.0047387. View

17.

Buter T, van den Hout A, Matthews F, Larsen J, Brayne C, Aarsland D . Dementia and survival in Parkinson disease: a 12-year population study. Neurology. 2008; 70(13):1017-22. DOI: 10.1212/01.wnl.0000306632.43729.24. View

18.

Gottesman R, Stern Y . Behavioral and Psychiatric Symptoms of Dementia and Rate of Decline in Alzheimer's Disease. Front Pharmacol. 2019; 10:1062. PMC: 6768941. DOI: 10.3389/fphar.2019.01062. View

19.

Albert M, DeKosky S, Dickson D, Dubois B, Feldman H, Fox N . The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7(3):270-9. PMC: 3312027. DOI: 10.1016/j.jalz.2011.03.008. View

20.

Angelucci F, Bernardini S, Gravina P, Bellincampi L, Trequattrini A, Di Iulio F . Delusion symptoms and response to antipsychotic treatment are associated with the 5-HT2A receptor polymorphism (102T/C) in Alzheimer's disease: a 3-year follow-up longitudinal study. J Alzheimers Dis. 2009; 17(1):203-11. DOI: 10.3233/JAD-2009-1031. View